Jauhar S, Johnstone M, Mckenna PJ. Schizophrenia. Lancet (London England). 2022;399(10323):473–86.
Google Scholar
Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in china: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–24.
Google Scholar
Chouinard S, Poulin J, Stip E, et al. Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophr Bull. 2004;30(4):957–67.
Google Scholar
Ferrarelli F. Sleep abnormalities in schizophrenia: state of the art and next steps. Am J Psychiatry. 2021;178(10):903–13.
Google Scholar
Bagautdinova J, Mayeli A, Wilson JD, et al. Sleep abnormalities in different clinical stages of psychosis: a systematic review and meta-analysis. JAMA Psychiatr. 2023;80(3):202–10.
Hou CL, Li Y, Cai MY, et al. Prevalence of insomnia and clinical and quality of life correlates in Chinese patients with schizophrenia treated in primary Care[J]. Perspect Psychiatr Care. 2017;53(2):80–6.
Google Scholar
Reeve S, Sheaves B, Freeman D. Sleep disorders in early psychosis: incidence, severity, and association with clinical symptoms. Schizophr Bull. 2019;45(2):287–95.
Google Scholar
Xiang YT, Weng YZ, Leung C-M, et al. Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients[J]. Sleep. 2009;32(1):105–9.
Google Scholar
Carruthers SP, Brunetti G, Rossell SL. Sleep disturbances and cognitive impairment in schizophrenia spectrum disorders: a systematic review and narrative synthesis. Sleep Med. 2021;84:8–19.
Google Scholar
Peng P, Li Z, Wang Q, et al. Insomnia moderates the association between positive symptoms and suicidal ideation: a large-scale cross-sectional study in Chinese patients with chronic schizophrenia. Gen Hosp Psychiatry. 2024;91:66–71.
Google Scholar
Ayers N, Mccall WV, Miller BJ. Sleep problems, suicidal ideation, and psychopathology in first-episode psychosis. Schizophr Bull. 2024;50(2):286–94.
Google Scholar
Ashton A, Jagannath A. Disrupted sleep and circadian rhythms in schizophrenia and their interaction with dopamine signaling. Front Neurosci. 2020;14: 636.
Google Scholar
Li W, Yang Y, An FR, et al. Prevalence of comorbid depression in schizophrenia: a meta-analysis of observational studies. J Affect Disord. 2020;273:524–31.
Google Scholar
De Winter L, Vermeulen JM, Couwenbergh C, et al. Short- and long-term changes in symptom dimensions among patients with schizophrenia spectrum disorders and different durations of illness: a meta-analysis. J Psychiatr Res. 2023;164:416–39.
Google Scholar
Buysse DJ, Angst J, Gamma A, et al. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–80.
Google Scholar
Nakajima S, Kaneko Y, Fujii N, et al. Transdiagnostic association between subjective insomnia and depressive symptoms in major psychiatric disorders. Front Psychiatry. 2023;14: 1114945.
Google Scholar
Zhu R, Wang D, Zhou H, et al. Sex differences in prevalence and clinical correlates of insomnia in Chinese patients with chronic schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2023;273(3):601–11.
Google Scholar
Boiko DI, Chopra H, Bilal M, et al. Schizophrenia and disruption of circadian rhythms: an overview of genetic, metabolic and clinical signs. Schizophr Res. 2024;264:58–70.
Google Scholar
Yan H, Huang Z, Lu Y, et al. Associations between metabolic disorders and sleep disturbance in patients with schizophrenia. Compr Psychiatry. 2023;122: 152369.
Google Scholar
Yan H, Li G, Zhang X, et al. Targeted metabolomics-based understanding of the sleep disturbances in drug-naïve patients with schizophrenia. BMC Psychiatry. 2024;24(1): 355.
Google Scholar
Gangadin SS, Enthoven AD, Van Beveren NJM, et al. Immune dysfunction in schizophrenia spectrum disorders. Annu Rev Clin Psychol. 2024;20(1):229–57.
Google Scholar
Halstead S, Siskind D, Amft M, et al. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis. Lancet Psychiatry. 2023;10(4):260–71.
Google Scholar
Lee EE, Ancoli-Israel S, Eyler LT, et al. Sleep disturbances and inflammatory biomarkers in schizophrenia: focus on sex differences. Am J Geriatr Psychiatry. 2019;27(1):21–31.
Google Scholar
Fang SH, Suzuki K, Lim CL, et al. Associations between sleep quality and inflammatory markers in patients with schizophrenia. Psychiatry Res. 2016;246:154–60.
Google Scholar
Irwin MR, Olmstead R, Carroll JE, Sleep, Disturbance. Sleep duration, and inflammation: A systematic review and Meta-Analysis of cohort studies and experimental sleep Deprivation[J]. Biol Psychiatry. 2016;80(1):40–52.
Google Scholar
Leucht S, Samara M, Heres S, et al. Dose equivalents for antipsychotic drugs: the DDD Method[J]. Schizophr Bull. 2016;42(Suppl 1Suppl 1):S90–4.
Google Scholar
Olié JP, Kasper S. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol. 2007;10(5):661–73.
Google Scholar
Xiang YT, Wong TS, Tsoh J, et al. Insomnia in older adults with chronic obstructive pulmonary disease (COPD) in Hong kong: a case-control study[J]. COPD. 2014;11(3):319–24.
Google Scholar
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
Google Scholar
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.
Google Scholar
Hao Y, Peng P, Wang Q, et al. Association between childhood maltreatment and suicidal ideation among Chinese patients with chronic schizophrenia: the mediating role of insomnia. BJPsych Open. 2024;10(3): e98.
Google Scholar
Zhou Y, Peng P, Yuan N, et al. Suicidal ideation in Chinese patients with chronic schizophrenia: prevalence, clinical correlates, and relationship with alexithymia. Eur Arch Psychiatry Clin Neurosci. 2024;274(7):1509–16.
Google Scholar
Addington D, Addington J, Atkinson M. A psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale. Schizophr Res. 1996;19(2–3):205–12.
Google Scholar
Xiao W, Liu H, Zhang H, et al. Reliability and validity of the Chinese version of the Calgary depression scale for schizophrenia. Aust N Z J Psychiatry. 2009;43(6):548–53.
Google Scholar
Duivis HE, De Jonge P, Penninx BW, et al. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry. 2011;168(9):913–20.
Google Scholar
Quidé Y, Bortolasci CC, Spolding B, et al. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder. Psychol Med. 2019;49(16):2736–44.
Google Scholar
Miller BJ, Mcevoy JP, Mccall WV, et al. Insomnia and triglycerides in schizophrenia. Schizophr Res. 2022;239:42–3.
Google Scholar
Batalla-Martín D, Belzunegui-Eraso A, Miralles Garijo E, et al. Insomnia in schizophrenia patients: prevalence and quality of life. Int J Environ Res Public Health. 2020;17(4): 1350.
Google Scholar
Mander BA, Winer JR, Walker MP. Sleep Hum Aging[J] Neuron. 2017;94(1):19–36.
Google Scholar
Van Erp TGM, Walton E, Hibar DP, et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol Psychiatry. 2018;84(9):644–54.
Google Scholar
Wulff K, Dijk DJ, Middleton B, et al. Sleep and circadian rhythm disruption in schizophrenia. Br J Psychiatry. 2012;200(4):308–16.
Google Scholar
Lawrence C, Marini CM. Loneliness and marital quality as predictors of older adults’ insomnia symptoms. Int J Aging Hum Dev. 2024;98(2):243–62.
Google Scholar
Wang M, Zhou Z, Tang W, et al. Regulatory t cells mediate insomnia-related psychotic symptoms and cognitive impairment in chronic schizophrenia patients. J Psychiatr Res. 2023;163:102–8.
Google Scholar
Waite F, Myers E, Harvey AG, et al. Treating sleep problems in patients with schizophrenia. Behav Cogn Psychother. 2016;44(3):273–87.
Google Scholar
Kluge M, Schacht A, Himmerich H, et al. Olanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literature. Schizophr Res. 2014;152(1):255–60.
Google Scholar
Li K, Qian L, Zhang C, et al. The entorhinal cortex and cognitive impairment in schizophrenia: a comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2025;136: 111218.
Google Scholar
Chu RST, Chu IWL, Yip EWC, et al. Cognitive functioning in people with psychotic experiences: a systematic review and meta-analysis study. Mol Psychiatry. 2025;30(3):1184–94.
Google Scholar
Laskemoen JF, Büchmann C, Barrett EA, et al. Do sleep disturbances contribute to cognitive impairments in schizophrenia spectrum and bipolar disorders? Eur Arch Psychiatry Clin Neurosci. 2020;270(6):749–59.
Google Scholar
Hall J. Schizophrenia – an anxiety disorder? Br J Psychiatry. 2017;211(5):262–3.
Google Scholar
Palmese LB, Degeorge PC, Ratliff JC, et al. Insomnia is frequent in schizophrenia and associated with night eating and obesity. Schizophr Res. 2011;133(1–3):238–43.
Google Scholar
Riemann D, Spiegelhalder K, Feige B, et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev. 2010;14(1):19–31.
Google Scholar
Upthegrove R, Marwaha S, Birchwood M. Depression and schizophrenia: cause, consequence, or Trans-diagnostic Issue?[J]. Schizophr Bull. 2017;43(2):240–4.
Google Scholar
Emsley R, Chiliza B, Asmal L, et al. The nature of relapse in schizophrenia. BMC Psychiatry. 2013;13: 50.
Google Scholar
Mosolov SN. Diagnosis and treatment depression in schizophrenia[J]. Consortium Psychiatricum. 2020;1(2):29–42.
Google Scholar
Furukawa Y, Nagaoka D, Sato S, et al. Cognitive behavioral therapy for insomnia to treat major depressive disorder with comorbid insomnia: a systematic review and meta-analysis. J Affect Disord. 2024;367:359–66.
Google Scholar
Krueger JM, Frank MG, Wisor JP, et al. Sleep function: toward elucidating an enigma. Sleep Med Rev. 2016;28:46–54.
Google Scholar
Capuron L, Miller AH. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther. 2011;130(2):226–38.
Google Scholar
Irwin MR, Opp MR, Sleep Health. Reciprocal regulation of sleep and innate Immunity[J]. Volume 42. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology; 2017. pp. 129–55. 1.
Veler H. Sleep and inflammation: bidirectional Relationship[J]. Sleep Med Clin. 2023;18(2):213–8.
Google Scholar
Prospéro-García O, Amancio-Belmont O, Becerril Meléndez AL, et al. Endocannabinoids and sleep. Neurosci Biobehav Rev. 2016;71:671–9.
Google Scholar
Seugnet L, Suzuki Y, Thimgan M, et al. Identifying sleep regulatory genes using a drosophila model of insomnia. J Neurosci. 2009;29(22):7148–57.
Google Scholar
Li R, Zhang Y, Zhu W, et al. Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis. Sci Rep. 2020;10(1): 17028.
Google Scholar
Wong KCY, Leung PBM, Lee BKW, et al. Long-term metabolic side effects of second-generation antipsychotics in Chinese patients with schizophrenia: a within-subject approach with modelling of dosage effects. Asian J Psychiatr. 2024;100: 104172.
Google Scholar
Sarandol E, Sarandol A, Mercan S, et al. Antipsychotic-treated schizophrenia patients develop inflammatory and oxidative responses independently from obesity: however, metabolic disturbances arise from schizophrenia-related obesity. Hum Psychopharmacol Clin Exp. 2024;39(6): e2913.